Publications by authors named "Satako Douguchi"

Claim this Profile
I
Imeglimin may affect hemoglobin A1c accuracy via prolongation of erythrocyte lifespan in patients with type 2 diabetes mellitus: insights from the INFINITY clinical trial.
Takeshi Osonoi, Shinichiro Shirabe, Miyoko Saito, Mitsuru Hosoya, Norie Watahiki, Satako Douguchi

Front Endocrinol (Lausanne)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, may substantially reduce serum urate levels, through URAT1 inhibition, potentially without adversely affecting ABCG2 function: findings from the SWITCH SURI study.
Takeshi Osonoi, Shinichiro Shirabe, Miyoko Saito, Mitsuru Hosoya, Norie Watahiki, Satako Douguchi

Front Endocrinol (Lausanne)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative evaluation of clinical glycemic control markers treated with imeglimin and its effect on erythrocytes in patients with type 2 diabetes mellitus: study protocol of a single-arm, open-label, prospective, exploratory trial.
Takeshi Osonoi, Shinichiro Shirabe, Miyoko Saito, Mitsuru Hosoya, Satako Douguchi

Front Pharmacol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dapagliflozin Improves Erythropoiesis and Iron Metabolism in Type 2 Diabetic Patients with Renal Anemia.
Takeshi Osonoi, Shinichiro Shirabe, Miyoko Saito, Mitsuru Hosoya, Norie Watahiki, Satako Douguchi

Diabetes Metab Syndr Obes· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of switching from febuxostat to dotinurad, a novel selective urate reabsorption inhibitor, in hyperuricemic patients with type 2 diabetic kidney disease: Protocol for a single-arm, open-label, prospective, exploratory study.
Takeshi Osonoi, Miyoko Saito, Mitsuru Hosoya, Satako Douguchi, Kensuke Ofuchi

Front Endocrinol (Lausanne)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liraglutide Improves Estimated Glomerular Filtration Rate Slopes in Patients with Chronic Kidney Disease and Type 2 Diabetes: A 7-Year Retrospective Analysis.
Takeshi Osonoi, Miyoko Saito, Yusuke Osonoi, Satako Douguchi, Kensuke Ofuchi

Diabetes Technol Ther· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Add-On Therapy with DPP-4 Inhibitors May Improve Renal Function Decline in α-Glucosidase Inhibitor and Metformin Users: A Retrospective Observational Study.
Takeshi Osonoi, Miyoko Saito, Naoya Koda, Satako Douguchi, Takako Nakano

Diabetes Metab Syndr Obes· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Four-year sequential nerve conduction changes since first visit in Japanese patients with early type 2 diabetes.
Mariko Kobori, Soroku Yagihashi, Norie Shiina, Nana Shiozawa, Akiko Haginoya, Satako Douguchi

J Diabetes Investig· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis